# Hour 04: 04:00-04:59 - Overnight Low Volume Operations

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Hour 04 continues overnight low-volume operations with 3 new arrivals taking
advantage of pre-dawn scheduling availability. Two patients from Hour 03
complete their observation periods and are discharged. Surgical robots begin
morning pre-operative calibration checks at 04:30 in preparation for the
daytime surgical schedule. No adverse events occur. Site PSL advances to 63.6.

## Site Status at 04:00

- Total patients on-site: 4 (P0003 recovery, P0005 pediatric, P0008 post-RT, P0009 post-biopsy)
- Active procedures: 0
- Robots in active mode: 1 (COMPN-03 passive monitoring)
- Robots in standby mode: 28
- Robots in maintenance: 0
- Queue length: 0 across all stations
- Site safety officer on duty: SSO-N1 (night shift)

## New Patient Arrivals

| Patient ID | Time | Age | Sex | Cancer Type | Stage | ECOG | Robot Needed |
|-----------|------|-----|-----|-------------|-------|------|-------------|
| PAT-ODMND-0010 | 04:10 | 55 | M | Parotid tumor | II | 0 | Needle-Placement (4) |
| PAT-ODMND-0011 | 04:25 | 48 | F | HCC | III | 1 | Imaging Assistant (8) |
| PAT-ODMND-0012 | 04:45 | 63 | M | Femur osteosarcoma (post-surgical) | N/A | 2 | Rehab Exoskeleton (10) |

Patient PAT-ODMND-0010 is a 55-year-old male with Stage II parotid tumor
presenting for early-morning CT-guided needle biopsy. He selected the 04:00
window to minimize time away from work. ECOG performance status 0. Procedure
plan: CT-guided fine needle aspiration of left parotid mass under local
anesthesia.

Patient PAT-ODMND-0011 is a 48-year-old female with Stage III hepatocellular
carcinoma presenting for liver imaging assessment. She selected an overnight
slot to reduce anxiety associated with daytime clinical environments. ECOG
performance status 1. Procedure plan: robotic ultrasound liver assessment for
treatment planning and digital twin calibration.

Patient PAT-ODMND-0012 is a 63-year-old male with post-surgical femur
osteosarcoma presenting for early rehabilitation session. He is 6 weeks
post-limb-salvage surgery and selected the pre-dawn slot due to personal
preference for early exercise. ECOG performance status 2. Procedure plan:
exoskeleton-assisted walking session for gait retraining.

## Continuing Patients at 04:00

| Patient ID | Age | Sex | Cancer Type | Status | Since |
|-----------|-----|-----|-------------|--------|-------|
| PAT-ODMND-0003 | 61 | M | Mediastinal tumor | Post-surgical recovery | 22:30 prior day |
| PAT-ODMND-0005 | 8 | M | Pediatric ALL | Overnight companion monitoring | 21:00 prior day |
| PAT-ODMND-0008 | 72 | M | Brain metastases | Post-RT observation | Hour 03 |
| PAT-ODMND-0009 | 34 | F | Sarcoma | Post-biopsy observation | Hour 03 |

## Active Procedures This Hour

### Needle Biopsy Session (04:15-04:40)
- Patient: PAT-ODMND-0010
- Robot: NEEDLE-01 (Needle-Placement, Instance 1)
- Bay: CT Suite 1
- Procedure: CT-guided fine needle aspiration of left parotid mass
- Duration: 25 minutes (positioning 3 min, CT scan 2 min, local anesthetic
  2 min, needle placement 3 min, aspiration 5 min, verification CT 3 min,
  needle removal 2 min, hemostasis 3 min, exit 2 min)
- Needle placement time: 3 minutes (within 1-3 min specification)
- CT guidance accuracy: 1.2 mm targeting deviation (within 2 mm tolerance)
- Tissue sample quality: Grade A (adequate for cytopathology)
- Local anesthetic: 2% lidocaine, 3 mL administered
- Bleeding: Minimal, controlled with manual pressure
- Treatment interruptions: 0
- Outcome: Successful completion. Sample sent to pathology.

Minute-by-minute summary (active procedure):
- 04:15 - Patient positioned supine with head turned right. CT landmarks placed.
- 04:16 - NEEDLE-01 arm positioned. Planning CT acquired.
- 04:17 - CT scan complete. Target coordinates calculated. AI trajectory planned.
- 04:18 - Local anesthetic administered to left parotid region.
- 04:19 - Anesthetic effect confirmed. Skin prep complete.
- 04:20 - Needle insertion initiated. NEEDLE-01 guiding 22-gauge needle.
- 04:21 - Needle tip at 18 mm depth. CT verification: on trajectory.
- 04:22 - Target reached. 1.2 mm from planned position. Acceptable.
- 04:23 - First aspiration pass. Syringe vacuum applied.
- 04:24 - Second aspiration pass. Redirected 2 mm laterally.
- 04:25 - Third aspiration pass. Sample adequacy confirmed by rapid assessment.
- 04:26 - Fourth pass for additional material (cytology block).
- 04:27 - Aspiration complete. Total 4 passes performed.
- 04:28 - Verification CT: no hemorrhage, no pneumothorax equivalent.
- 04:29 - Verification CT review complete. No complications.
- 04:30 - Needle withdrawn. Manual pressure applied.
- 04:31 - Hemostasis achieved. Bandage applied.
- 04:32 - Patient assisted to seated position. No dizziness reported.
- 04:38 - 5-minute observation at bedside. Stable.
- 04:40 - Patient transferred to observation area. Procedure complete.

### Imaging Assessment (04:30-04:45)
- Patient: PAT-ODMND-0011
- Robot: IMAGE-01 (Imaging Assistant, Instance 1)
- Bay: Imaging Bay 1
- Procedure: Robotic ultrasound liver assessment
- Duration: 15 minutes
- Probe pressure: 1.5 N steady (within 1-3 N range)
- Image quality score: 7.8/10
- Tumor measurements: Primary HCC lesion 52 mm x 41 mm, satellite lesion
  14 mm x 11 mm
- Scan coverage: 94%
- Motion artifact count: 1 (minor, auto-compensated)
- Outcome: Successful. Images uploaded to DICOM server for treatment planning
  and digital twin calibration.

### Rehabilitation Session (04:50-05:10)
- Patient: PAT-ODMND-0012
- Robot: REHAB-01 (Rehabilitation Exoskeleton, Instance 1)
- Bay: Rehab Bay 1
- Procedure: Exoskeleton-assisted walking session
- Duration: 20 minutes (strap-up 3 min, walking 15 min, removal 2 min)
- Walking speed: 0.3 m/s (prescribed rehabilitation pace)
- Distance covered: 270 meters
- Gait symmetry index: 0.72 (improving from 0.65 at 4 weeks post-op)
- Weight-bearing compliance: 85% on affected limb (target: 80-100%)
- Pain reported: 3/10 during walking, 2/10 at rest
- Treatment interruptions: 0
- Outcome: Successful session. Patient tolerated full duration. Data logged
  for rehabilitation progress tracking.

Note: REHAB-01 session extends into Hour 05 (04:50-05:10). Start-of-session
documented here; completion will be logged in Hour 05.

## Patient Departures This Hour

| Patient ID | Time | Outcome | Notes |
|-----------|------|---------|-------|
| PAT-ODMND-0008 | 04:05 | Discharged | Post-RT observation complete, stable vitals |
| PAT-ODMND-0009 | 04:20 | Discharged | Post-biopsy observation complete, no complications |

## Adverse Events

None this hour.

## Investigational Drug Administrations

None this hour. All procedures are standard-of-care diagnostic and
rehabilitative interventions.

## Surgical Robot Pre-Operative Calibration (04:30)

SURG-01, SURG-02, and SURG-03 initiated morning pre-operative calibration
checks at 04:30. This is a standard daily procedure performed before the
first surgical case of the day. Calibration includes:
- Positional accuracy verification (6-DOF, all axes)
- Force sensor zero-point calibration
- Instrument tracking system alignment
- Camera focus and white balance adjustment
- AI model warm-up (inference latency test)
- Estimated completion: 05:15 (45 minutes per standard protocol)

## Site Utilization

- Overall robot utilization: 8% (3 of 29 robots active at procedure points)
- Queue lengths: 0 across all stations
- Average wait time: 5 minutes (P0010: 5 min, P0011: 5 min, P0012: 5 min)
- Robot cleaning cycles: 2 (NEEDLE-01 post-procedure, IMAGE-01 post-procedure)

## End-of-Hour Census

| Patient ID | Age | Sex | Cancer Type | Status | Location |
|-----------|-----|-----|-------------|--------|----------|
| PAT-ODMND-0003 | 61 | M | Mediastinal tumor | Post-surgical recovery | Recovery Bay 3 |
| PAT-ODMND-0005 | 8 | M | Pediatric ALL | Overnight monitoring | Pediatric Ward |
| PAT-ODMND-0010 | 55 | M | Parotid tumor | Post-biopsy observation | Recovery Bay 5 |
| PAT-ODMND-0011 | 48 | F | HCC | Post-imaging observation | Imaging Bay 1 |
| PAT-ODMND-0012 | 63 | M | Femur osteosarcoma | Active rehab session | Rehab Bay 1 |

Total patients on-site at 04:59: 5

## Regulatory Compliance Notes

### ICH E6(R3) - Adaption
- Section 1.1.1: All procedures conducted in accordance with ethical principles
  and applicable GCP requirements. Overnight operations maintained identical
  safety standards to daytime operations. Pre-dawn arrivals accommodated per
  on-demand scheduling protocol.
- Section 2.9.1: Complete audit trail maintained for CT-guided needle biopsy
  including needle trajectory coordinates, CT verification images, and tissue
  sample chain-of-custody documentation.
- Section 4.2.1: Data capture for imaging session included probe pressure
  measurements at 50 Hz, image quality metrics, and tumor measurements with
  synchronized UTC timestamps. Rehabilitation session captured gait metrics
  at 100 Hz for digital twin integration.

### 21 CFR Part 50 - Adaption
- Section 50.25: All three new patients (PAT-ODMND-0010, PAT-ODMND-0011,
  PAT-ODMND-0012) had previously completed informed consent including Physical
  AI system disclosure, USL readiness scores, and right to non-Physical AI
  alternatives.
- Section 50.30: Pre-procedure safety matrix completed for all procedures:
  authorization verified, patient identity confirmed, clinical data accessed
  via FHIR, robot readiness confirmed, environmental checks passed.

### 21 CFR Part 312 - Adaption
- Section 312.62: Investigator recordkeeping maintained for all patients
  including Physical AI system interaction logs, vital sign records, and
  procedure outcome documentation.
- Section 312.32: Safety reporting systems active and monitoring all patients.
  No reportable events this hour.

### 21 CFR Part 820 - Adaption
- Section 820.72: Surgical robot calibration checks (SURG-01 through SURG-03)
  conducted per equipment qualification protocol. Calibration records maintained
  with timestamps, deviation measurements, and pass/fail criteria documentation.

## Complementary Framework References

The Unification Standard Level (USL) framework (Kawchak, 2026;
DOI: 10.5281/zenodo.18778220) provides complementary robot technical
interoperability scoring. NEEDLE-01 and IMAGE-01 operate on platforms evaluated
at USL scores consistent with the Advanced band, reflecting strong sensor
fusion and AI integration capabilities for CT-guided and ultrasound procedures.
See physical-ai-oncology-trials/unification/usl/paper/usl_oncology_trials.tex.

The single-patient cancer journey framework (Kawchak, 2026;
DOI: 10.5281/zenodo.19119939) demonstrated autonomous Physical AI trial
orchestration for an individual patient. PAT-ODMND-0012's rehabilitation
session represents Stage 7-equivalent recovery support within a multi-patient,
multi-cancer-type, on-demand operational context.
See physical-ai-oncology-trials/patient-journey/paper/patient_journey_paper.tex.
